Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024

Stifel Reiterates Hold Rating on Summit Therapeutics plc (SMMT)

February 24, 2025 1:40 PM EST

Stifel analyst Brad Canino reiterated a Hold rating and $40.00 price target on Summit Therapeutics plc (NASDAQ: SMMT)

The analyst comments "Todays volatility is likely recent M&A conjecture falling out after management canceled three 1Q bank conferences, and less of a... More